Drugs / Subcutaneous immunotherapy (SCIT)
Subcutaneous immunotherapy (SCIT)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01335139 | Mar 2011 → Feb 2015 | seasonal allergic rhinitis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Subcutaneous immunotherapy (SCIT) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01335139 ↗ |
| Modality | Other / unclassified | “subcutaneous injection immunotherapy” NCT01335139 ↗ |
| Route | Subcutaneous | “subcutaneous immunotherapy (monthly injections containing 20 µg of Phleum p 5)” PMID 28196255 ↗ Feb 2017 |